መነሻ › በርኪት ሊምፎማ › Wisconsin

በWisconsin ለበርኪት ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለበርኪት ሊምፎማ የሚደረጉ 17 ጥናቶች በWisconsin ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በWisconsin ውስጥ ያሉ ከተሞች

Official study text (English)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Saint Vincent Hospital Cancer Center Green Bay, Green Bay
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Children's Hospital of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 2

366 Days – 46 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Marshfield Medical Center-Marshfield, Marshfield
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03150693

Blinatumomab Consolidation in Real World

Medical College of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Children's Hospital of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Marshfield Medical Center-EC Cancer Center, Eau Claire
Marshfield Medical Center-Marshfield, Marshfield
Froedtert Menomonee Falls Hospital, Menomonee Falls
እና 8 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Saint Vincent Hospital Cancer Center Green Bay, Green Bay
Children's Hospital of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 2

365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Medical College of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Medical College of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Saint Vincent Hospital Cancer Center Green Bay, Green Bay
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Children's Hospital of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Saint Vincent Hospital Cancer Center Green Bay, Green Bay
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Marshfield Medical Center-Marshfield, Marshfield
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT06137118

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Froedtert & the Medical College of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ18 እስከ 81 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05990465

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

Children's Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይ

እድሜ ከ0 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT05794880

Study of SGR-1505 in Mature B-Cell Neoplasms

Medical College of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT05544019

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኖቬም 2025 · NCT03375619

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

University of Wisconsin Carbone Cancer Center, Madison

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ15 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT04150497

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Children's Hospital of Wisconsin, Milwaukee

ተሳታዮችን በመፈለግ ላይደረጃ 2

እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2021 · NCT04746209

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።